AY026312 Activators
Chemical activators of keratin associated protein 19-9B utilize various signaling pathways to influence the activity of this protein. Acetylcholine acts through muscarinic receptors on epithelial cells, triggering a cascade of intracellular events that upregulate the protein's function. Similarly, epinephrine engages adrenergic receptors, leading to an increase in intracellular cAMP, which stimulates protein kinase A (PKA) and culminates in the activation of keratin associated protein 19-9B. Retinoic acid and calcitriol both function through receptor-mediated mechanisms, with retinoic acid binding to its specific receptors and calcitriol to the vitamin D receptor. These interactions can modify gene expression patterns, thereby impacting the functionality of keratin associated protein 19-9B.
Additional compounds such as Calcium Ionophore A23187 raise the intracellular calcium concentration, which in turn activates keratin associated protein 19-9B through calcium-dependent pathways. Phorbol 12-Myristate 13-Acetate (PMA) directly activates protein kinase C (PKC), which also augments the activity of keratin associated protein 19-9B. In contrast, Bisindolylmaleimide I, while primarily known as a PKC inhibitor, can selectively modulate specific PKC isoforms, thereby influencing the activity of keratin associated protein 19-9B. U0126 operates by inhibiting MEK, which can lead to compensatory activation of keratin associated protein 19-9B within the MAPK signaling pathway. Lithium Chloride, through its inhibitory action on GSK-3β, can also result in the protein's activation. Furthermore, Forskolin, by activating adenylyl cyclase, increases cAMP levels and consequently activates PKA, which influences the protein's activity. Synthetic analogs like 1,2-Dioctanoyl-sn-glycerol (DiC8) and Ionomycin mimic natural activators by activating PKC and increasing intracellular calcium levels, respectively, further promoting the activation of keratin associated protein 19-9B.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine activates keratin associated protein 19-9B through adrenergic receptors which could lead to intracellular cAMP increase, PKA activation, and subsequent activation of proteins involved in cytoskeletal organization. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid activates keratin associated protein 19-9B by binding to retinoic acid receptors, which may alter gene expression and protein function in keratinocytes, influencing keratin protein activity. | ||||||
1α,25-Dihydroxyvitamin D3 | 32222-06-3 | sc-202877B sc-202877A sc-202877C sc-202877D sc-202877 | 50 µg 1 mg 5 mg 10 mg 100 µg | $220.00 $645.00 $1000.00 $1500.00 $440.00 | 32 | |
Calcitriol binds to the vitamin D receptor, which can activate keratin associated protein 19-9B through VDR-mediated signaling pathways that influence cellular differentiation and protein function in the skin. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium Ionophore A23187 increases intracellular calcium concentration, which can activate keratin associated protein 19-9B through calcium-dependent signaling pathways that modulate cytoskeletal protein function. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can activate keratin associated protein 19-9B through PKC-mediated signaling pathways that influence cytoskeletal organization and keratin protein function. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a PKC inhibitor, but it can selectively activate keratin associated protein 19-9B by modulating PKC isoforms involved in the specific signaling pathways that govern keratin protein function and assembly. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK, which might result in the compensatory activation of keratin associated protein 19-9B as part of a feedback mechanism within the MAPK signaling pathway that regulates keratinocyte function. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride inhibits GSK-3β, which can lead to the activation of keratin associated protein 19-9B as GSK-3β is involved in the regulation of protein synthesis and cytoskeletal organization. | ||||||
1,2-Dioctanoyl-sn-glycerol | 60514-48-9 | sc-202397 sc-202397A | 10 mg 50 mg | $47.00 $254.00 | 2 | |
DiC8 is a synthetic diacylglycerol which can mimic DAG, activating PKC which in turn can activate keratin associated protein 19-9B as part of the signaling cascade that affects keratinocyte function and cytoskeletal dynamics. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which can activate keratin associated protein 19-9B through calmodulin-dependent kinase pathways, leading to the activation of proteins that regulate cytoskeleton and keratin filament organization. | ||||||